FAQ for Sites during COVID-19
Date: April 2, 2020
Time: 12:00PM - 01:00PM
You must be registered to participate!
Please join us for an FAQ session led by David Vulcano, Vice President, Research Compliance & Integrity for HCA Healthcare, on how sites can ensure compliance through COVID-19.
- Identify how COVID-19 response is affecting clinical trial sites.
- Discuss how clinical trial sites are responding to various COVID-19 related challenges.
- List the current enforcement discretions that the US government is allowing during this declared emergency.
David Vulcano, Vice President, Research Compliance & Integrity for HCA Healthcare